Snapshot

The Conditional Marketing Authorisation Applications (CMA) pathway has been developed by the Medicines and Healthcare products Regulatory Agency (MHRA) of United Kingdom.

This pathway can be used where Medicinal products that fulfill an unmet medical need. .

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Info not found.